Non-clinical toxicological considerations for pharmaceutical salt selection

By Thackaberry Evan A  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 8, Iss. 11, 2012-11 ,pp. : 1419-1433

Informa Healthcare

Access to resources Recommend Favorite

Nonclinical strategy considerations for safety pharmacology: evaluation of biopharmaceuticals

By Vargas Hugo M   Amouzadeh Hamid R   Engwall Michael J  

Expert Opinion on Drug Safety, Vol. 12, Iss. 1, 2013-01 ,pp. : 91-102

Informa Healthcare

Access to resources Recommend Favorite

Fusion of nonclinical and clinical data to predict human drug safety

By Johnson Dale E  

Expert Review of Clinical Pharmacology, Vol. 6, Iss. 2, 2013-03 ,pp. : 185-195

Informa Healthcare

Access to resources Recommend Favorite

Pharmacogenomic data submissions to the FDA: non-clinical case studies

By Leighton John K   DeGeorge Joseph   Jacobson-Kram David   MacGregor James   Mendrick Donna   Worobec Alexandra  

Pharmacogenomics, Vol. 5, Iss. 5, 2004-07 ,pp. : 507-511

Future Medicine

Access to resources Recommend Favorite

Oral Antidiabetic Agents: A Guide to Selection

By Scheen J.   Lefèbvre P.J.  

Drugs, Vol. 55, Iss. 2, 1998-02 ,pp. : 225-236

Adis International

Access to resources Recommend Favorite